Aevis Victoria (AEVS.SW) Stock Price
Aevis Victoria Price
Over the last 19 years Aevis Victoria grew revenue by 28.6% annually, reaching 1.13 B CHF. Earnings per share have grown at 40.0% per year over the last 14 years. For Aevis Victoria, the net margin of -1.8% is down versus -0.5% a few years ago. At today's price the dividend yield works out to roughly 5.10%. The dividend has grown at 28.7% per year over the past 10 years. The consensus 12-month price target for Aevis Victoria is 17.34 CHF, about 18.0% above where the stock trades today. Of 7 analysts, 6 rate the stock a buy — an overall Buy consensus.
Aevis Victoria stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Aevis Victoria business model & stock analysis
Frequently asked questions about Aevis Victoria
Aevis Victoria SA is a healthcare company with a diversified business model. It operates in the areas of acute care hospitals, post-acute care facilities, medical clinics, and health networks. Aevis Victoria SA aims to provide high-quality medical services, combining modern infrastructure and cutting-edge technology. The company's diverse portfolio includes private hospitals, rehabilitation clinics, residential care centers, and other healthcare facilities. Aevis Victoria SA is committed to offering comprehensive and patient-centric care, implementing innovative medical solutions, and continuously enhancing the overall healthcare experience. With its strong presence and expertise in the healthcare industry, Aevis Victoria SA strives to deliver exceptional services and contribute to improving the overall well-being of individuals and communities.
Aevis Victoria SA is primarily active in the healthcare and hospitality industries.
The main competitors of Aevis Victoria SA in the market include Swiss Medical Network, Mediclinic International, and Infracore SA.
Aevis Victoria SA is a leading healthcare and hospitality company headquartered in Switzerland. Established in 1995, Aevis Victoria SA has a rich history and background in providing exceptional services in the healthcare industry. Over the years, the company has expanded its operations to include a wide range of healthcare facilities, including private hospitals, clinics, and medical services. Aevis Victoria SA has also ventured into the hospitality sector, managing luxury hotels and resorts. With a strong commitment to quality and innovation, Aevis Victoria SA has gained a reputation for delivering excellent healthcare and hospitality experiences.
Aevis Victoria SA has achieved several significant milestones. The company expanded its healthcare division by acquiring Swiss Medical Network, one of the largest private hospital networks in Switzerland. Aevis Victoria SA also made strategic investments in the hospitality industry, acquiring luxury hotel and tourism assets. In addition, the company launched a digital health platform called Medgate, providing telemedicine services. Aevis Victoria SA has further extended its presence by acquiring minority stakes in various healthcare companies. Overall, Aevis Victoria SA has demonstrated a track record of successful acquisitions and investments, expanding its portfolio and solidifying its position in both the healthcare and hospitality sectors.
Aevis Victoria SA is primarily present in Switzerland.
Aevis Victoria SA represents values of excellence, innovation, and integrity in its corporate philosophy. As a leading company in the healthcare and hospitality sectors, Aevis Victoria SA focuses on delivering superior services and enhancing the well-being of its clients. With a commitment to sustainability and social responsibility, the company aims to contribute positively to the communities it operates in. Aevis Victoria SA prioritizes customer satisfaction, providing personalized experiences and maintaining highest standards in quality. By championing continuous improvement and fostering a culture of collaboration, Aevis Victoria SA assures stakeholders of their dedication to long-term success and creating value in their respective industries.
Analysts currently set an average price target of 17.34 CHF for the Aevis Victoria stock (median: 17.34 CHF), implying +18.0 % versus the latest price. The consensus is based on 7 analyst ratings.
7 analysts currently rate the Aevis Victoria stock: 6 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Aevis Victoria to generate revenue of 1.09 B CHF and earnings per share of 0.11 CHF.
Converted at the current exchange rate, the Aevis Victoria share trades at 15.82 EUR (14.70 CHF).
The Aevis Victoria share (AEVS.SW) is listed on 2 stock exchanges, including: SIX (Zürich) (AEVS.SW), Frankfurt (G5LN.F).
Aevis Victoria SA is an internationally operating company that is active in the fields of Life Sciences, Hospitality, and Lifestyle. The company is headquartered in Lausanne, Switzerland and is listed on the Swiss SIX Swiss Exchange. The Life Sciences division of Aevis Victoria SA focuses on the development, manufacturing, and marketing of medical devices and medications. This includes artificial joints, implantable pacemakers, and insulin pumps. The company partners with leading healthcare organizations worldwide and works closely with renowned research institutes to develop innovative solutions for medical problems. The Hospitality division of Aevis Victoria SA encompasses a variety of luxury hotels and resorts throughout Europe. Some of the well-known brands include The Alpina Gstaad in Switzerland, Ushuaïa Ibiza Beach Hotel in Spain, and Miraggio Thermal Spa Resort in Greece. The Hospitality division aims to provide its guests with an unforgettable experience by setting the luxury standard in the industry and offering excellent customer service. The Lifestyle division of Aevis Victoria SA focuses on the marketing of exclusive lifestyle products such as fashion, jewelry, and watches. This includes brands like Caran d'Ache, de Grisogono, and Peter Zwack. The Lifestyle division strives to delight its customers through a combination of elegance and style and deliver products of the highest quality. Aevis Victoria SA aims to provide customers with a seamless shopping experience by selling its products online and in physical stores worldwide. The company's strategy is based on the development of innovative products and services that cater to the needs of its customers. Additionally, the company aims to expand its strong presence in Europe and Asia to strengthen its position in the global market. Overall, the business model of Aevis Victoria SA combines innovative research and development, excellent customer service, and a wide range of products. The company aims to be a leading player in the fields of Life Sciences, Hospitality, and Lifestyle and provide its customers with an unforgettable experience through excellent products and services. With its strong brand portfolio and global presence, the company is well-positioned to continue growing and strengthen its position in the global market.
The expected revenue of Aevis Victoria is 1.09 B CHF. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Aevis Victoria is 9.51 M CHF. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Aevis Victoria is currently 130.50. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Aevis Victoria stock.
The price-to-sales ratio (P/S) of Aevis Victoria is currently 1.14. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Aevis Victoria stock.
The Eulerpool Quality Score for Aevis Victoria is 2/10.
The ISIN of Aevis Victoria is CH0478634105. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Aevis Victoria is A2PLW7. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Aevis Victoria is AEVS.SW. The ticker symbol is used to trade Aevis Victoria shares on the stock exchange.
Aevis Victoria stock
Aevis Victoria Peer Group
Aevis Victoria Ticker
Aevis Victoria FIGI
All fundamentals and in-depth analysis of Aevis Victoria
Our stock analysis for Aevis Victoria stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Aevis Victoria. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.